The U.S. Department of Agriculture’s Food Safety and Inspection Service is announcing its intention to redesign its E. coli O157:H7 verification testing program for beef manufacturing trimmings to make the program “more risk-based” and to run ongoing statistical prevalence estimates for E. coli O157:H7 in raw beef trimmings. The notice, published in the Federal Register Wednesday, also discusses FSIS’s plans to perform a beef carcass baseline. “FSIS seeks public comment on its plans, which have been developed in response to a 2011 audit by the U.S. Department of Agriculture’s Office of Inspector General (OIG) of FSIS’s protocol for N-60 sampling of beef manufacturing trimmings for E. coli O157:H7,” reads the notice. In 2010, FSIS’s sampling program came under harsh criticism from the OIG and the government auditor made a number of recommendations to the agency. The announcement also says that FSIS has made changes to its beef manufacturing trimmings program to increase both the collection rate and the likelihood that FSIS will find positive samples. The notice points out several changes, including that the agency has increased sampling through the “high prevalence season” for E. coli, which is May through October in the United States. “Because of resource constraints, however, increased sampling during the high-prevalence season will require a decrease in sampling during the low prevalence season.” The agency notes that it is likely that the changes in sampling will increase the probability of obtaining E. coli O157:H7 positive results in beef manufacturing trimmings during FSIS verification testing by a factor of about 2.5. FSIS welcomes interested stakeholders to comment on the changes. Comments may be submitted via the Federal eRulemaking Portal. Go to http://www.regulations.gov and follow the online instructions at that site for submitting comments.
The News Desk team at Food Safety News covers breaking developments, regulatory updates, recalls, and key topics shaping food safety today. These articles are produced collaboratively by our editorial staff.
A leading academic has warned that any plans for UK regulators to help industry grow could end up repeating past mistakes and impacting public health.
As part of modernization plans,
The FDA has issued final guidance for manufacturers of infant formula and laboratories conducting testing on infant formula.
The guidance was developed to help manufacturers and laboratories in the design,
As part of its enforcement activities, the Food and Drug Administration sends warning letters to entities under its jurisdiction. Some letters are not posted for public view until weeks or
The a2 Milk Company (“a2MC”) has recalled three specific batches of its imported a2 Platinum Premium USA label infant formula 0-12 months because of the presence of cereulide. The product
JXK Enterprises Inc. is recalling Boner Bears Chocolate, Lot #BB21125, after being notified that FDA laboratory analysis confirmed the presence of sildenafil, an active ingredient in the FDA-approved prescription drug
Total Nutrition Inc. of Deer Park, NY, is recalling TNVitamins Ultra Potent Complete Green Superfood and Doctor’s Pride Complete Green Superfood Ultra Potent Moringa Capsules because they have the
Bazzini LLC, of Allentown, PA, a co-manufacturer utilized by SkinnyDipped, is recalling a limited number of cases of SkinnyDipped Dark Chocolate Coconut Almond Bites, because of the possible presence of
